Skip to main content

Table 3 Comparisons between male and female OSA patients

From: Epidemiological characteristics and gender-specific differences of obstructive sleep apnea in a Chinese hypertensive population: a cross-sectional study

Variables

Female

Male

P value

N (%)

148 (21.6)

537 (78.4)*

<0.001

Age (years)

62.8 ± 10.2

58.4 ± 11.9*

<0.001

BMI (Kg/m2)

26.2 ± 4.2

25.6 ± 4.1

0.136

SBP (mm Hg)

139.8 ± 21.4

136.7 ± 21.5

0.111

DBP (mm Hg)

79.1 ± 15.1

79.4 ± 14.1

0.831

AHI

18.0 ± 15.4

23.1 ± 16.8*

0.001

IVS (mm)

10.7 ± 1.8

11.6 ± 2.4*

<0.001

LVPW (mm)

9.9 ± 1.6

10.7 ± 1.8*

<0.001

HbA1c (%)

6.6 ± 1.4

6.2 ± 1.1*

0.001

Creatinine (μmol/L)

81.7 ± 38.7

103.7 ± 52.2*

<0.001

BUN (mmol/L)

5.7 ± 3.5

5.8 ± 2.6

0.836

FPG (mmol/L)

7.0 ± 3.4

6.3 ± 2.8*

0.015

Triglyceride (mmol/L)

1.8 ± 0.2

1.8 ± 0.3

0.619

Total cholesterol (mmol/L)

4.7 ± 1.4

4.5 ± 1.2*

0.019

LDL-C (mmol/L)

2.8 ± 1.1

2.7 ± 0.9

0.092

HDL-C (mmol/L)

1.1 ± 0.3

1.0 ± 0.2

0.947

Proteinuria (%)

14.9

21.9

0.289

Diabetes mellitus (%)

33.8

21.8*

0.003

Dyslipidemia (%)

23.0

12.3*

0.001

Aortic dissection (%)

10.8

22.3*

0.002

Aneurysm (%)

1.4

6.5*

0.014

CHD (%)

37.8

43.0

0.258

Cerebrovascular disease (%)

12.8

9.1

0.181

Heart failure (%)

25.0

21.0

0.303

Atrial fibrillation (%)

12.8

8.0

0.070

HCM (%)

4.1

3.2

0.595

Anti-platelet (%)

55.4

54.0

0.762

Statins (%)

68.2

66.5

0.687

ACEI (%)

19.6

22.7

0.417

ARB (%)

43.2

46.7

0.450

Beta-blocker (%)

60.8

68.0

0.102

Alpha-blocker (%)

3.4

7.3

0.088

CCB (%)

60.8

56.1

0.300

Diuretic (%)

18.9

18.6

0.935

Warfarin (%)

10.1

6.3

0.112

  1. Denote: BUN blood uria nitrogen, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CHD coronary heart disease, HCM hypertrophy cardiomyopahty, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker
  2. *P < 0.05 versus female group